We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Scientific Session Explores Role of Technology in New Era of Specimen Transport

By LabMedica International staff writers
Posted on 27 Jul 2023
Print article
Image: Plans for new CLSI documents addressing specimen preanalytics were shared at AACC 2023 (Photo courtesy of CLSI)
Image: Plans for new CLSI documents addressing specimen preanalytics were shared at AACC 2023 (Photo courtesy of CLSI)

Regardless of a lab's scale or complexity, patient samples require transportation prior to testing. From moving specimens across a room to shipping them globally, all labs inevitably encounter challenges at some point. The AACC 2023 session titled "Advances in Courier, Drone, and Automated Laboratory Transport" empowered attendees with the understanding of how issues and inefficiencies in sample transport could impact test results. Moreover, the session also threw light on how emerging technologies can be harnessed to streamline testing and maintain specimen quality.

Session moderator Joe Wiencek, Ph.D. from the Vanderbilt University School of Medicine (Nashville, TN, USA) argued that despite the critical role of patient specimens in testing, the sector hasn't paid adequate attention to specimen transport conditions. At his institution, Wiencek has employed innovative devices to record conditions during specimen transport, such as temperature, humidity, and G-forces. He expressed considerable concern over the practice at external collection sites of storing samples in outdoor lockboxes while waiting for courier pick-up, particularly given the intense heat in his region. However, in the absence of benchmarks and standards for specimen transport, it's challenging for laboratories to take proactive steps. Wiencek shared plans for new Clinical and Laboratory Standards Institute (CLSI, Berwyn, PA, USA) documents that address specimen preanalytics, particularly PRE-06 Evaluation of External Transport Systems, which he is co-authoring. The attendees left the session equipped with a set of tools to overcome their sample transport hurdles.

Timothy Amukele, MD, from ICON Clinical Research (Farmingdale, MD, USA) expanded the discussion about external sample transport by introducing the concept of medical drone transport. While medical drones might seem like a concept straight out of a science fiction novel for some, they are very much a reality in certain parts of the world. Dr. Amukele highlighted how African governments are leading the charge in harnessing these technologies effectively. He cited the example of Rwanda, where drones are used to deliver life-saving blood products to remote hospitals, along with similar implementations in other countries. Dr. Amukele believes that these success stories are noteworthy and succeeded in convincing the attendees of the viability of medical drones in specimen transportation.

However, the application of drone transportation isn't limited to isolated regions. There's considerable interest in deploying this technology in densely populated urban areas as well. Dr. Amukele shared his personal experience of spearheading a medical drone research team in the United States, shedding light on the steps required to establish a medical drone transport network. He stressed that medical drones have already shown their worth in real-world applications and expressed his wish to see their usage further expand within laboratory practice.

Jonathan Genzen, MD, Ph.D., from ARUP Laboratories (Salt Lake City, UT, USA) shifted the focus of the discussion to sample transportation and automation within healthcare facilities and laboratories. His objective at his institution is to automate routine, non-value-adding steps in the testing process, thereby allowing professionals to concentrate on complex tasks that demand human expertise. Genzen recounted his experiences in integrating automated intelligent vehicles for sample transportation. These non-track-based mobile robots are suitable for specimen distribution and are equipped with sensors to navigate their surroundings, avoiding collisions with objects and individuals. He also discussed lessons in automation derived from the COVID-19 pandemic. Attendees gained insights into how they can modernize their specimen transport procedures. Genzen emphasized that labs can implement simple, easy improvements to reap substantial benefits from minimal investments.

Related Links:
Vanderbilt University
ICON Clinical Research
ARUP Laboratories 
CLSI

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac
New
Centrifuge
Hematocrit Centrifuge 7511M4

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.